Vapotherm Inc
F:VA21
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Coastal Roadways Ltd
BSE:520131
|
IN |
|
Medcom Tech SA
MAD:MED
|
ES |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (12.9), the stock would be worth €-4.84 (263% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -7.9 | €2.98 |
0%
|
| Industry Average | 12.9 | €-4.84 |
-263%
|
| Country Average | 14.4 | €-5.39 |
-281%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| US |
V
|
Vapotherm Inc
F:VA21
|
137.6m EUR | -7.9 | -2.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.6B USD | 15.9 | 27.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.4B USD | 42.6 | 56.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.3B USD | 19.7 | 38.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.6B USD | 13.4 | 24.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
104.1B USD | 20.8 | 35.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.7B USD | 23.6 | 43 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41B EUR | 10.8 | 19.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.7B USD | 29.8 | 42 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.8B USD | 9.9 | 25.1 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.6B USD | 11 | 15.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 14.4 |
| 70th Percentile | 21.5 |
| Max | 1 767 274.1 |
Other Multiples
Vapotherm Inc
Glance View
Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. The company is headquartered in Exeter, New Hampshire and currently employs 510 full-time employees. The company went IPO on 2018-11-14. The firm is focused on the care of patients of all ages suffering from the respiratory distress often associated with complex lung diseases, such as chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), pneumonia, asthma and COVID-19. Its device solutions are focused on high velocity nasal insufflation (HVNI), which delivers non-invasive ventilatory support to patients suffering from respiratory distress. Its HVNI technology delivers heated, humidified and oxygenated air at a high velocity through a small-bore nasal interface. The company offers four versions of its Precision Flow systems, which includes Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Its Precision Flow systems include a capital unit, a single-use disposable and a nasal interface. Its digital solutions are focused on at home patient monitoring. The firm also provides various clinical solutions.
